COG — Cambridge Cognition Holdings Share News
0.000.00%
Last trade - 00:00- £15.85m
- £15.59m
- £9.40m
RCS - Cambridge Cognition - Investor Presentation via Investor Meet Company
AnnouncementREG - Cambridge Cognition - £1.12m Placing & Subscription, TVR & PDMR Dealings
AnnouncementREG - Cambridge Cognition - Changes to Board and Management
AnnouncementREG - Cambridge Cognition - Interim Results
AnnouncementRCS - Cambridge Cognition - Monument Therapeutics Partnership with FNIH
AnnouncementREG - Cambridge Cognition - Launch of Speaker Identification Solution
AnnouncementREG - Cambridge Cognition - Trading update for period ended 30 June 2025
AnnouncementREG - Cambridge Cognition - Result of AGM
AnnouncementRCS - Cambridge Cognition - Monument Therapeutics Success in Phase I Results
AnnouncementREG - Cambridge Cognition - Notice of AGM
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Preliminary Unaudited Results
AnnouncementREG - Cambridge Cognition - Notice of Results and Investor Presentation
AnnouncementREG - Cambridge Cognition - Contract Win
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Contract Win
AnnouncementREG - Cambridge Cognition - Block Listing Return
AnnouncementRCS - Cambridge Cognition - CANTAB® used for major global brain health study
AnnouncementRCS - Cambridge Cognition - Cambridge Cognition submits FDA Letter of Intent
Announcement